Development and Characterization of Thermoreversible In-situ Gel Containing Curcumin Nanoparticles for Nasal Delivery: Design, Ex-Vivo Study
Abstract
The present study aimed to develop and evaluate thermoreversible in situ nasal gel containing Curcumin nanoparticles. Curcumin nanoparticles were prepared by the ionic gelation method. These formulations were evaluated for entrapment efficiency, particle size, zeta potential, and In vitro drug release. Particle size and zeta potential of F1 formulation were found to be 299 nm, 0.1 mV, and entrapment efficiency was found to be87.2%. From the formulations, F1 shows maximum amount of drug released in a sustained manner for a prolonged period time. Hence F1formulation was selected as optimized and further used for thermoreversible in situ nasal gel by using 2×2 factorial designs. The thermoreversible nasal gel was evaluated for the gelation temperature (33˚C), viscosity (10550cps) and spreadability (17.29±0.3 gm*cm/sec). Further, the prepared gel (F1G3) was evaluated for ex vivo permeation study for12 hours and it shows maximum amount of drug release in a controlled manner. The % CDR of thermoreversible in situ gel formulation F1G3 was found to be 86.27% which follow the Higuchi model. The 'n' value of the formulation was found to be more than 0.5. This indicate that the release approximates the non-fickain diffusion mechanism.
Keywords: Curcumin nanoparticles, Carbopol 934, PF127, Thermoreversible in situ gel, Cold method, Nasal delivery.
Keywords:
Curcumin nanoparticles, Carbopol 934, PF127, Thermoreversible in situ gel, Cold method, Nasal deliveryDOI
https://doi.org/10.22270/jddt.v14i2.6411References
Appasaheb PS, Manohar SD, Bhanudas SR, Anjaneri N. A review on intranasal drug delivery system. J Adv Pharm Educ Res.2013;3(4):333-46.
Illum L. Nasal drug delivery: Possibilities, problems and solutions. J Control Release, 2003; 87(3): 187-98. https://doi.org/10.1016/S0168-3659(02)00363-2 PMid:12618035
Khan S, Patil K, Bobade N, et al. Formulation of intranasal mucoadhesive temperature mediated in situ gel containing Ropinirole and evaluation of brain targeting efficiency in rats. J Drug Target, 2010; 18(3): 223-34. https://doi.org/10.3109/10611860903386938 PMid:20030503
Kulkarni AD, Vanjari YH, Sancheti KH, Belgamwar VS, Surana SJ, Pardeshi CV. Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini-review. J Drug Target. 2015 Oct 21;23(9):775-88 https://doi.org/10.3109/1061186X.2015.1020809 PMid:25758751
Ruel-Gariepy E, Leroux J-C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur J Pharm Biopharm. 2004;58(2):409-26. https://doi.org/10.1016/j.ejpb.2004.03.019 PMid:15296964
Peppas N, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000;50(1):27-46. 12. https://doi.org/10.1016/S0939-6411(00)00090-4 PMid:10840191
Koffi A, Agnely F, Ponchel G, Grossiord J. Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine. Eur J Pharm Sci. 2006;27(4):328-35. 13. https://doi.org/10.1016/j.ejps.2005.11.001 PMid:16356700
Gratieri T, Gelfuso GM, Rocha EM, Sarmento VH, de Freitas O, Lopez RFV. A poloxamer/chitosan in situ forms a gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm. 2010;75(2):186-93. https://doi.org/10.1016/j.ejpb.2010.02.011 PMid:20188828
Nesalin JA, Smith AA. Preparation and evaluation of chitosan nanoparticles containing zidovudine. Asian J Pharm Sci. 2012 Feb 4;7(1):80-4.
Sharma S, Lohan S, Murthy RS. Formulation and characterization of intranasal mucoadhesive nanoparticulate and thermo-reversible gel of levodopa for brain delivery. Drug development and industrial pharmacy. 2014 Jul 1;40(7):869-78. https://doi.org/10.3109/03639045.2013.789051 PMid:23600649
Pandey R, Ahmad Z, Sharma S, et al. Nanoencapsulation of azole antifungals: Potential applications to improve oral drug delivery. Int J Pharm. 2005, 301: 268-276 https://doi.org/10.1016/j.ijpharm.2005.05.027 PMid:16023808
Nasra MM, Khiri HM, Hazzah HA, Abdallah OY. Formulation, in-vitro characterization, and clinical evaluation of curcumin in-situ gel for treatment of periodontitis. Drug Deliv. 2017 Jan 1;24(1):133-42. https://doi.org/10.1080/10717544.2016.1233591 PMid:28156166 PMCid:PMC8241198
Srivastava RI, Srivastava SA, Singh SP. Thermoreversible in-situ nasal gel formulations and their pharmaceutical evaluation for the treatment of allergic rhinitis containing extracts of moringa olifera and Emelia tribes. Int J Appl Pharm. 2017;9(6):16. https://doi.org/10.22159/ijap.2017v9i6.18780
Begum SG, Sekar M. Formulation and evaluation of tinidazole mucoadhesive buccal gels. Int J Pharma Bio Sci 2017;8:48-55. https://doi.org/10.22376/ijpbs.2017.8.2.p48-55
Gilbert JC, Richardson JL, Davies MC, Palin KJ, Hadgraft J. The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J control release. 1987 Sep 1;5(2):113-8. https://doi.org/10.1016/0168-3659(87)90002-2
Athare A and Rohamare P. Formulation and evaluation of eletriptan hydrobromide thermoreversible nasal in-situ gel. Int J Pharma Res Development. 2012; 4(04): 267-275.
Bansal K, Rawat MK, Jain A, Rajput A, Chaturvedi TP, Singh S. Development of Satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS Pharm Sci Tech, 2009; 10(3): 716-23. 19. https://doi.org/10.1208/s12249-009-9260-z PMid:19479385 PMCid:PMC2802163
Tan YT, Peh KK, Al-Hanbali O. Effect of Carbopol and polyvinylpyrrolidone on the mechanical, rheological, and release properties of bioadhesive Polyethylene glycol gels. AAPS Pharm Sci Tech, 2000; 1(3): 69-78. https://doi.org/10.1208/pt010324 PMid:14727910 PMCid:PMC2750352
Published



How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).